Article ID Journal Published Year Pages File Type
8245214 International Journal of Radiation Oncology*Biology*Physics 2006 9 Pages PDF
Abstract
Conclusions: Capecitabine 725 mg/m2 p.o., twice daily in combination with oxaliplatin 50 mg/m2/week and RT 50.4 Gy in 28 fractions is the recommended dose for future studies.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
Authors
, , , , , , , ,